These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2237113)

  • 1. Tuberculous psoas muscle abscess following chemoprophylaxis with isoniazid in a patient with human immunodeficiency virus infection.
    Johnson SC; Stamm CP; Hicks CB
    Rev Infect Dis; 1990; 12(5):754-6. PubMed ID: 2237113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoas abscess due to retroperitoneal tuberculous lymphadenopathy.
    Perros P; Sim DW; MacIntyre D
    Tubercle; 1988 Dec; 69(4):299-301. PubMed ID: 3257007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal meningitis due to psoas abscess.
    Scott BD; Schmidt JH
    South Med J; 1989 Oct; 82(10):1310-1. PubMed ID: 2799451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human immunodeficiency virus infection and tuberculosis: who should receive chemoprophylaxis?].
    Moreno Guillén S
    Rev Clin Esp; 1994 Feb; 194(2):73-4. PubMed ID: 8008942
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of the 12 months course of antituberculous chemoprophylaxis in HIV infection.
    Di Perri G; Vento S; Cruciani M; Marocco S; Mazzi R; Concia E; Bassetti D
    J Infect; 1992 Jan; 24(1):108-9. PubMed ID: 1548412
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspects of tuberculosis in Africa. 1. Tuberculosis in Africa in the AIDS era--the role of chemoprophylaxis.
    Porter JD; McAdam KP
    Trans R Soc Trop Med Hyg; 1992; 86(5):467-9. PubMed ID: 1475804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive PPD and chemoprophylaxis for tuberculosis infection.
    Pickwell SM
    Am Fam Physician; 1995 Jun; 51(8):1929-34, 1937-8. PubMed ID: 7762484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient.
    Mendes-Bastos P; Brás S; Carvalho R
    Int J STD AIDS; 2018 Jun; 29(7):720-722. PubMed ID: 29256823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent solitary tuberculous psoas abscess 52 years after healed thoracolumbar tuberculous spondylitis.
    Korovessis P; Papadaki E; Repanti M; Stamatakis M
    Spine (Phila Pa 1976); 1995 Aug; 20(15):1709-12. PubMed ID: 7482022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of psoas abscess in the Human Immunodeficiency Virus era.
    Aboobakar R; Cheddie S; Singh B
    Asian J Surg; 2018 Mar; 41(2):131-135. PubMed ID: 27938929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. A decision analysis.
    Jordan TJ; Lewit EM; Montgomery RL; Reichman LB
    JAMA; 1991 Jun; 265(22):2987-91. PubMed ID: 2033771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal penetration by tuberculous psoas abscess.
    Blumenthal DH; Morin ME; Tan A; Li YP
    AJR Am J Roentgenol; 1981 May; 136(5):995-7. PubMed ID: 6784541
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilateral tuberculosis psoas abscess in a human immunodeficiency virus-positive patient: a case report.
    Olasinde AA; Munihire JB; Mugenyi M; Kasereka FT; Adetan O; Bankole JK
    J Med Case Rep; 2024 Sep; 18(1):446. PubMed ID: 39317928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin.
    Mathivha KT; Velaphi S
    Paediatr Int Child Health; 2017 May; 37(2):129-134. PubMed ID: 27455907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.